Seek Returns

INSM vs. MTD: Insmed vs. Mettler-Toledo Stock Comparison

How do Insmed (INSM) and Mettler-Toledo (MTD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Insmed (INSM) and Mettler-Toledo (MTD) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but INSM is classified in Biotechnology while MTD is classified in Life Sciences Tools & Services.

Company profile comparison for Insmed (INSM) and Mettler-Toledo (MTD)
Profile ItemINSMMTD
NameInsmed IncorporatedMettler-Toledo International Inc.
Country/RegionUnited StatesSwitzerland
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnologyLife Sciences Tools & Services
GICS Sub-IndustryBiotechnologyLife Sciences Tools & Services
Market Capitalization25.10 billion USD34.25 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateJune 1, 2000November 14, 1997
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

INSM
MTD
GSPC
Loading price history…
Insmed (INSM) vs. Mettler-Toledo (MTD), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Insmed (INSM) and Mettler-Toledo (MTD). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Insmed (INSM) and Mettler-Toledo (MTD). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Insmed (INSM) and Mettler-Toledo (MTD)
MetricINSMMTD
Total Return (1Y)-39.17%21.58%
Total Return (3Y, Annualized)70.17%19.54%
Total Return (5Y, Annualized)28.96%2.36%

Risk Profile

Drawdown History

INSM
MTD
GSPC
Loading price history…
Insmed (INSM) vs. Mettler-Toledo (MTD), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Insmed (INSM) and Mettler-Toledo (MTD). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Insmed (INSM) and Mettler-Toledo (MTD)
MetricINSMMTD
Volatility (1Y, Annualized)63.09%31.70%
Beta (5Y)0.801.15
Max Drawdown (5Y)-56.54%-43.47%
Avg. Volume (3M)2.76M197.80K

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
INSM and MTD are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Insmed (INSM) and Mettler-Toledo (MTD)
MetricINSMMTD
Sharpe Ratio (1Y)-0.690.55
Sortino Ratio (1Y)-1.040.75

Profitability

ROE (TTM)

Mettler-Toledo (MTD) has no ROE value reported for this period; Insmed (INSM) reports a negative figure of -72.45%, which needs context because negative ROE can reflect losses or negative shareholders’ equity.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-72.45%

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
INSM
-72.45%
Min
-167.77%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
MTD
--
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): MTD does not report ROE, so it has no value marker; INSM is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Insmed (INSM) reports a negative net margin of -39.85%, usually indicating a net loss over the period. Meanwhile Mettler-Toledo (MTD) reports 22.25%, ranking against industry peers normally.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-39.85%

Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
INSM
-39.85%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

22.25%

MTD
22.25%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Insmed (INSM) reports a negative operating margin of -15.60%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Mettler-Toledo (MTD) reports 28.70%, ranking against industry peers normally.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-15.60%

Max
83.12%
Q3
14.77%
Median
0.00%
INSM
-15.60%
Q1
-78.82%
Min
-207.40%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

28.70%

Max
83.12%
MTD
28.70%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Insmed (INSM) and Mettler-Toledo (MTD)
MetricINSMMTD
ROE (TTM)-72.45%--
ROA (TTM)-17.25%20.09%
Net Margin (TTM)-39.85%22.25%
Operating Margin (TTM)-15.60%28.70%
Gross Margin (TTM)84.40%59.16%

Growth

Revenue Growth

Insmed (INSM) at 66.73% sits in the top revenue growth quartile, while Mettler-Toledo (MTD) at 3.98% is closer to the peer norm — faster top-line expansion for INSM.

Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Mettler-Toledo (MTD) reports EPS growth of 3.88%, ranked against its industry; Insmed (INSM) has no EPS growth figure this period.

Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Insmed (INSM) and Mettler-Toledo (MTD)
MetricINSMMTD
Revenue Growth (YoY)66.73%3.98%
Revenue Growth (3Y CAGR)35.20%0.90%
EPS Growth (YoY)--3.88%
EPS Growth (3Y CAGR)--3.06%

Financial Strength

Current Ratio (MRQ)

Insmed (INSM) at 2.86 keeps current ratio within its industry’s typical mid-range, while Mettler-Toledo (MTD) at 1.10 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for MTD.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.86

Max
25.13
Q3
12.13
Median
5.52
INSM
2.86
Q1
2.47
Min
0.10

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.10

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
MTD
1.10
Min
0.10
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Both balance sheets lean debt-heavy versus peers, but MTD is more stretched: Insmed (INSM) at 1.01 sits in the higher-leverage quartile and Mettler-Toledo (MTD) at 26.06 is above its industry benchmark range.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.01

Max
1.42
INSM
1.01
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

26.06

MTD
26.06
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Insmed (INSM) and Mettler-Toledo (MTD)
MetricINSMMTD
Current Ratio (MRQ)2.861.10
Debt / Equity (MRQ)1.0126.06
Net Debt / EBITDA--1.58

Dividends

Dividend Yield (TTM)

Neither Insmed (INSM) nor Mettler-Toledo (MTD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

INSM
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MTD
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Insmed (INSM) nor Mettler-Toledo (MTD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

INSM
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MTD
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Insmed (INSM) and Mettler-Toledo (MTD)
MetricINSMMTD
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Mettler-Toledo (MTD) trades at 37.38 times trailing earnings, ranked against its peers, while Insmed (INSM) has no P/E ratio this period.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
INSM
--

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

37.38

Max
85.34
Q3
43.46
MTD
37.38
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): INSM does not report P/E ratio, so it has no value marker; MTD is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

On P/S ratio, both Insmed (INSM) at 16.52 and Mettler-Toledo (MTD) at 8.16 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.52

Max
58.18
Q3
25.77
INSM
16.52
Median
7.30
Q1
3.01
Min
0.01

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max
58.18
Q3
25.77
MTD
8.16
Median
7.30
Q1
3.01
Min
0.01
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Measured against book value, both Insmed (INSM) at 34.55 and Mettler-Toledo (MTD) at 442.71 look expensive — each P/B ratio sits above its industry’s benchmark range.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

34.55

INSM
34.55
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

442.71

MTD
442.71
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
Insmed (INSM) vs. Mettler-Toledo (MTD): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Insmed (INSM) and Mettler-Toledo (MTD)
MetricINSMMTD
P/E Ratio (TTM)--37.38
P/S Ratio (TTM)16.528.16
P/B Ratio (MRQ)34.55442.71
Free Cash Flow Yield (TTM)-1.82%1.97%